List of insiders holdings for ENDOLOGIX INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ELLIOTT INTERNATIONAL L.P. 10% Owner | 2010-12-16 16:20:31 | 3,318,002 0 | 3,318,002 | Form 4 |
| ESSEX WOODLANDS HEALTH VENTURES FUND VII LP 10% Owner | 2016-02-12 12:48:30 | 1,257,468 0 | 1,257,468 | Form 13G |
| ELLIOTT ASSOCIATES L.P. 10% Owner | 2011-08-15 15:09:31 | 969,399 0 | 969,399 | Form 13D |
| McDermott John D Director | 2018-05-30 18:51:41 | 879,423 0 | 879,423 | Form 4 |
| Chavez Christopher G. Director | 2018-05-30 19:39:15 | 378,346 0 | 378,346 | Form 4 |
| Mitchell Robert D President | 2017-06-20 10:50:38 | 316,886 0 | 316,886 | Form 4 |
| BUCHBINDER MAURICE Director | 2004-10-25 17:33:48 | 298,294 0 | 298,294 | Form 4 |
| HENSON MICHAEL R Director | 2003-11-18 16:19:56 | 0 209,095 | 209,095 | Form 4 |
| Chobotov Michael V. Chief Technology Officer | 2016-09-26 11:03:40 | 203,269 0 | 203,269 | Form 4/A |
| BISHOP JOSEPH A Vice President Research & Devl | 2003-12-12 18:10:06 | 180,000 0 | 180,000 | Form 4 |
| UYESUGI KAREN Vice President | 2007-10-30 20:03:14 | 166,900 0 | 166,900 | Form 4 |
| Onopchenko John CEO and Director | 2020-08-14 19:57:00 | 165,698 0 | 165,698 | Form 4 |
| O'Quinn Shari L VP, Clinical & Regulatory | 2017-06-06 09:55:26 | 159,356 0 | 159,356 | Form 4 |
| DeJohn Joseph A. General Manager, Asia & Pac | 2016-07-11 10:54:48 | 153,471 0 | 153,471 | Form 4 |
| Krist Robert John Chief Financial Officer | 2012-12-31 13:10:19 | 142,236 0 | 142,236 | Form 4 |
| SCHRECK STEFAN Vice President | 2013-10-15 20:37:23 | 140,136 0 | 140,136 | Form 4 |
| Hawkins Daniel Vice Pres - Global Marketing | 2009-04-14 18:41:59 | 125,000 0 | 125,000 | Form 4 |
| Mahboob Vaseem Chief Financial Officer | 2020-03-26 16:36:18 | 111,716 0 | 111,716 | Form 4 |
| Kiernan Jane E Director | 2020-03-18 16:32:31 | 103,847 0 | 103,847 | Form 4 |
| Fauls Janet Mary VP Regulatory Affairs | 2015-06-01 10:28:50 | 101,346 0 | 101,346 | Form 4 |
| BROWN FRANKLIN D Director | 2011-11-04 17:35:24 | 94,700 0 | 94,700 | Form 4 |
| Abraham Todd VP of Operations | 2015-11-17 11:15:47 | 86,821 0 | 86,821 | Form 4 |
| Ferracci Cecile General Manager, Europe | 2016-02-17 16:18:11 | 81,286 0 | 81,286 | Form 4 |
| Lima Jose A. VP-Quality | 2016-08-22 16:28:20 | 70,855 0 | 70,855 | Form 4 |
| Mertens Herbert H Vice President of Sales/Mktg | 2005-02-25 19:30:10 | 70,000 0 | 70,000 | Form 4 |
| Thunen Shelley B Named Executive Officer | 2015-10-21 14:42:28 | 53,995 0 | 53,995 | Form 4 |
| Thompson Matthew Chief Medical Officer | 2020-08-14 18:47:44 | 52,878 0 | 52,878 | Form 4 |
| THIEL JEFFREY H Director | 2004-01-06 18:29:28 | 0 51,192 | 51,192 | Form 4/A |
| Jennings David M. VP-Human Resources | 2016-06-02 16:00:05 | 50,281 0 | 50,281 | Form 4 |
| Nagel Laura VP, Quality | 2018-03-15 16:23:44 | 48,860 0 | 48,860 | Form 4 |
| Love Charles Steele VP-Clinical Affairs | 2016-01-28 13:30:58 | 45,037 0 | 45,037 | Form 4 |
| Zenty III Thomas F Director | 2019-08-06 17:28:30 | 44,570 0 | 44,570 | Form 4 |
| DePalma Amanda L. VP, Global Marketing | 2016-06-02 15:59:49 | 43,772 0 | 43,772 | Form 4 |
| NEELS GUIDO J Director | 2019-04-03 16:09:22 | 43,200 0 | 43,200 | Form 4 |
| Zehren John Chief Commercial Officer | 2020-01-09 21:21:43 | 40,138 0 | 40,138 | Form 4 |
| Sorsher Gary I. Vice President - Quality | 2013-10-01 14:45:32 | 40,120 0 | 40,120 | Form 4 |
| DIETHRICH EDWARD Director | 2008-05-23 16:59:21 | 40,000 0 | 40,000 | Form 4 |
| Norwalk Leslie V Director | 2019-08-06 17:16:59 | 38,955 0 | 38,955 | Form 4 |
| Machek James Edward VP-Research & Development | 2016-06-02 16:02:01 | 38,286 0 | 38,286 | Form 4 |
| HAYDEN JEREMY B. General Counsel | 2019-10-07 18:35:51 | 32,040 0 | 32,040 | Form 4 |
| RICHARDS DAVID M Chief Financial Officer & Secr | 2004-08-03 15:10:24 | 30,546 0 | 30,546 | Form 4 |
| Greenstein Leonard M. VP Finance & Corp Controller | 2013-10-04 11:58:59 | 28,518 0 | 28,518 | Form 4 |
| Lyons Ruth Anne VP Global Marketing | 2014-03-18 12:13:49 | 27,168 0 | 27,168 | Form 4 |
| Fecho Jeff Chief Quality Officer | 2020-08-07 20:19:50 | 23,732 0 | 23,732 | Form 4 |
| ODONNELL JEFFREY F Director | 2010-05-24 14:11:41 | 20,000 0 | 20,000 | Form 4 |
| Coelyn Ronald H Director | 2007-05-23 18:56:44 | 20,000 0 | 20,000 | Form 4 |
| Tyler Martin VP, International | 2013-03-15 18:29:19 | 14,472 0 | 14,472 | Form 4 |
| DE GREEF RODERICK Director | 2013-03-08 18:25:37 | 7,102 0 | 7,102 | Form 4 |
| Pinto Cynthia Buch Interim CFO | 2020-08-14 18:04:04 | 6,304 0 | 6,304 | Form 4 |
| Brady Timothy Nicholas Controller and Corp Secretary | 2020-08-14 18:51:10 | 891 0 | 891 | Form 4 |
| WALLER GREGORY D Director | 2020-08-14 20:04:11 | 710 0 | 710 | Form 4 |
| MCCORMICK PAUL Director | 2010-05-03 19:50:31 | 332.69 0 | 332.69 | Form 4 |
| Camber Capital Management LP 10% Owner | 2020-02-14 09:35:10 | 0 0 | 0 | Form 13G |
| MOTT RICHARD W Director | 2020-07-07 21:09:30 | 0 0 | 0 | Form 3 |
| Wilder Thomas Director | 2020-08-14 18:49:02 | 0 0 | 0 | Form 4 |
| Lemaitre Dan Director | 2020-09-17 16:35:50 | 0 0 | 0 | Form 4 |